There is my probabilities1- We lauch aristotle with success. We keep doing covid testing with Biden money. The share price slowly increase to $5 cnd and we can get an uplist to Nasdaq. We get more interest from US ETF and investors 2- Aristotle is delay and the price drop sub $1 3- Aristotle is a failure and the share price tank crazy 4- There is a buyout on the table in the next 2 years. We could be bought by a big pharma or a compagny like Exact science. A vote must be submitted to the shareholders. Imagine a compagny who sell chemio. They can detect the cancer early and start selling their chemio earlier. You gotta know how expensive it is. I work as a nurse and I have done few contracts for Shoppers drug mart IV med divison. I have given Erbitux which is a colon cancer chemio for malignancy tumors. Basically more palliative as these people will die anyway. Around 4K per dose. I have given once a chemio for malignant skin cancer. Can't remember the name. One dose was 90k and wasnt cover by the Quebec insurance. The most expensive given by my collegue was 165k for one shot. That been said, I don't think a buyout can happen under 2 billions. SZLS fully diluted with all these warrants brings about 71m shares. 2B=$28.71/share 3B=$42.25/share I sit on 38k shares. Half TFSA, half RSP. Bring a 2B buyout. I ll be very happy with nearly 1M in my account